LOGIN HERE
STAR Data Period 2011-01-01 - 2011-10-15Date uploaded 2011-10-15

Recent Publications

NameCitation
Allaire, Dr. CatherineReid R, Leyland N, Wolfman W, Allaire C, Awadalla A, Best C, Dunn S, Lemyre M, Marcoux V, Menard C, Potestio F, Rittenberg D, Singh S, Senikas V; Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines: Oral contraceptives and the risk of venous thromboembalism: an update: no. 252, December 2010. Int J Gynaecol Obstet. 2011 Mar:112(3):252-6.
Allaire, Dr. CatherineMohtashami F, von Dadelszen P, Allaire C. A Surgical Virtual Reality Simulator, the SurgicalSim, Distinguishes between Expert Gynaecological Laparoscopic Surgeons and Perinatologists, J SLS, in press.
Butler, Dr. BlairAlexander E, Butler RK, Guimond C, Butler B, Sadovnick AD. Accuracy of Reported Family History and Effectiveness of Medical Records Requests in Genetic Counselling for Alzheimer Disease. J Genet Couns 2011 Apr;20(2):129-35.
Butler, Dr. BlairHiggins L, Butler B, du Souich C. Women's Understanding of Prenatal Ultrasound and Soft Markers. ACMG Annual Clinical Genetics Meeting, Vancouver, BC. March 16-20, 2011.
Carey, Dr. MarkNieman KM, Kenny HA, Ladanyi A, Penicka C, Buell-Gutbrod R, Carey MS, Zillhardt MR, Hotamisligil G, Mills GM, Haney AF, Yamada SD, Peter ME, Gwin K, Lengyel E. Adipocytes promote ovarian cancer metastasis and provide the energy for rapid tumor growth. Nature Medicine.
Carey, Dr. MarkGonzalez-Angulo AM, Hennessy BY, Meric-Bernstam F, Sahin A, Liu W, Ju Z, Carey MS, Myhre S, Speers C, Lei D, Broaddus R, Lluch AM, Aparicio S, Brown P, Pusztai L, Symmans F, Alsner J, Overgaard J, Borresen-Dale AL, Hortobagyi GN, Coombes KR, Mills GB. Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer. Clin Proteomics.
Carey, Dr. MarkCarey MS, Gotay C. Patient-Reported Outcomes: Clinical Trials in Ovarian Cancer. Int J Gynecol Cancer 2011;21: 782-787.
Carey, Dr. MarkAnglesio MS, Carey MS, Köbel M, MacKay H, Vancouver Ovarian Clear Cell Symposium Speakers, Huntsman DG. Cell Carcinoma of the Ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010, Gynecologic Oncology.
Carey, Dr. MarkMcConechy MK, Anglesio MS, Kalloger SE, Yang W, Senz J, Chow C, Heravi-Moussavi A, Morin GB, Mes-Masson A-M, Australian Ovarian Cancer Study Group, Carey MS, McAlpine JN, Kwon JS, Prentice LM, Boyd N, Shah SP, Gilks CB, Huntsman DG. Subtype Specific Mutation of PPP2R1A in Endometrial and Ovarian Carcinomas. Journal of Pathology.
Carey, Dr. MarkPerren T.J, Swart A.M, Pfisterer J, Ledermann J.A., Pujade- Lauraine E., Kristensen G., Carey M.S., Beale P., Cervantes A., Kurzeder, C., du Bois A., Sehouli J., Kimmig R., Stähle A., Collinson F., Essapen S., Gourley C., Lortholary A., Selle F., Mirza M.R., Leminen, A.,Plante M., Stark D., Qian W. Ph.D., Parmar M.K.B., Oza A. Bevacizumab in Ovarian Cancer: ICON7- A Phase III Gynecologic Cancer InterGroup Trial. New England Journal of Medicine.
Carey, Dr. MarkRavi D, Chen Y, Karia B, Brown A, Gu TT, Li J, Carey MS Hennessey BT, Bishop AJR. 14-3-3 Sigma expression effects G2/M response to oxygen and correlates with ovarian cancer metastasis. PLOS Medicine.
Ehlen, Dr. Thomas G.Vergote I, Ehlen T. Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc-IV ovarian cancer. Journal of Clinical Oncology.
Ehlen, Dr. Thomas G.Vergote I, Amant F, Kristensen G, Ehlen T, Reed N, Casado A. The role of neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer. 4th European Symposium on Ovarian Cancer. Reims, France. June 23 - 24, 2011.
Ehlen, Dr. Thomas G.Kwon JS, Mazgani M, Miller DM, Ehlen T, Heywood M, McAlpine JN, Finlayson SJ, Plante M, Stuart GC, Carey MS. The significance of surgical staging in intermediate-risk endometrial cancer. Gynecologic Oncology 2011 Mar 19. [Epub ahead of print].
Ehlen, Dr. Thomas G.Cantor SB, Yamal JM, Guillaud M, Cox DD, Atkinson EN, Benedet JL, Miller D, Ehlen T, Matisic J, van Niekerk D, Bertrand M, Milbourne A, Rhodes H, Malpica A, Staerkel G, Nader-Eftekhari S, Adler-Storthz K, Scheurer ME, Basen-Engquist K, Shinn E, West LA, Vlastos AT, Tao X, Beck JR, Macaulay C, Follen M. Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy. Int J Cancer. 2011 M
Fitzsimmons, Dr. Brian P.Veiga, Lam, Gemeinhardt, Houlihan, Fitzsimmons, Hodgson. Social support in the post-abortion recovery room: evidence from patients, support persons and nurses in a Vancouver clinic. 14 September 2010, Contraception, March 2011 (Vol. 83, Issue 3, Pages 268-273).
Fluker, Dr. Margo R.Hanna CW, Ghahremani M, Bretherick KL,Cotton A, Fluker MR, Brown CJ, Robinson WP. DNA methylation at the androgen receptor gene: Implications for X chromosome inactivation skewing assays and idiopathic premature ovarian failure. Submitted, European Journal of Human Genetics, Mar 2011.
Gagnon, Dr. Alain L.Audibert F, Gagnon A + SOGC Genetics Committee. "Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies." JOGC July 2011 33(7):754-767.
Gagnon, Dr. Alain L.SOGC Diagnostic Imaging Cte; Special Contributor + SOGC Genetics Cte (Member). Ultrasound in Twin Pregnancies. JOGC 2011:33(6);643-656.
Geoffrion, Dr. RoxanaGeoffrion R, Choi J, Lentz G, Training Surgical Residents: The Current Canadian Perspective Journal of Surgical Education.
Geoffrion, Dr. RoxanaGeoffrion R, Murphy M, Robert M, Birch C, Ross S, Tang S, Milne J. Vaginal Paravaginal Repair with Porcine Small Intestine Submucosa: long-term outcomes Female Pelvic medicine and Reconstructive Surgery Journal.
Geoffrion, Dr. RoxanaHalwani Y, Oakes J, Leipsic J, Geoffrion R, Wiseman SM. Transvaginal Incarcerated Hernia of the Small Bowel after an Abdominal Sacrocolpopexy: a case report and literature review, Journal Hernia.
Geoffrion, Dr. RoxanaYong P, Garrey M, Geoffrion R. Transvaginal Repair and Graft Interposition for Rectovaginal Fistula due to a Neglected Pessary: case report and review of the literature; Female Pelvic Medicine and Reconstructive Surgery Journal.
Gomel, Dr. VictorGomel V. in "Laparoscopic Surgery in Infertility and Gynecology" Jain N. Editor, Jaypee, New Delhi, 2011.
Kwon, Dr. Janice S.McConechy MK, Anglesio MS, Kalloger SE, Yang W, Senz J, Chow C, Heravi-Moussavi A, Morin GB, Mes-Masson, AM, Aust Ov Ca Study Group, Carey MS, McAlpine JN, Kwon, JS, Prentice LM, Boyd N, Shah SP, Gilks CB, Huntsman DG. “Subtype specific mutation of PPP2R1A in endometrial and ovarian carcinomas”. J Pathol 2011. In press.
Lim, Dr. Kenneth I.Morin L, Lim K (Principal Authors) SOGC Diagnostic Imaging Cte, Special Contributor, and SOGC Genetics Cte. Ultrasound in Twin Pregnancies. JOGC 2011;33(6):643-656.
Ma, Dr. SaiChan Wong E, Hatakeyama C, Minor A, Ma S. DNA methylation at H19 /IGF2 ICR1 in the placenta of SGA pregnancies conceived by IVF and ICSI. Fertil Steril 30: 2524-2526 (2011).
Ma, Dr. SaiKirkpatrick G, Chow V, Ma S. A systematic study of meiotic recombination, synapsis, meiotic inactivation and sperm aneuploidy in a carrier with chromosome 1 inversion. Reprod BioMed Online (accepted) (2011).
Ma, Dr. SaiMinor A, Chow V, Ma S. Aberrant DNA methylation at imprinted genes in testicular sperm retrieved from men with obstructive azoospermia and post vasectomy reversal. Reproduction 141:749-57 (2011).
Mayer, Dr. ChantalJain VD, Moghbeli N, Webb G, Srinivas SK, Elovitz MA, Paré E. Pregnancy in women with congenital heart disease: the impact of a systemic right ventricle. Congenit Heart Dis. 2011 Mar;6(2):147-56. doi: 10.1111/j.1747-0803.2011.00497.x. Epub 2011 Mar 21.
McAlpine, Dr. Jessica N.Chiang S, Ali R, Melnyk N, McAlpine JN, Huntsman DG, Gilks CB, Lee CH, Olivia E. Frequency of known gene rearrangements in endometrial stromal tumors. Am J Surg Pathol. 2011 Sep; 35 (9): 1364-72.
McAlpine, Dr. Jessica N.Wells T, Plante M, McAlpine JN; The Communities of Practice Groups on behalf of the Society of Gynecologic Oncologists of Canada. Preoperative bowel preparation in gynecologic oncology: a review of practice patterns and an impetus to change. Int J Gynecol Cancer. 2011 Aug; 21(6):1135-1142.
McAlpine, Dr. Jessica N.Stany M, Ozbun L, Vathipadiekal V, Stone R, Mok S, Xue H, Kagami T, Wang Y, McAlpine J, Gout P, Miller D, Gilks B, Huntsman D, Ellard S, Wang YZ, Vivas-Mejia P, Lopez-Berestein G, Sood A, Birrer M. Identification of Novel Therapeutic Targets in Microdissected Human Clear Cell Ovarian Cancers: A Genomic Approach for Personalized Medicine. PLoS One. 2011;6(7):e21121. Epub 2011 Jul 6.
McAlpine, Dr. Jessica N.Kwon J, Mazgani M, Miller DM, Ehlen T, Heywood M, McAlpine JN, Finlayson S, Plante M, Stuart G, Carey M. The significance of surgical staging in intermediate-risk endometrial cancer. Gynecologic Oncology 2011 Jul; 122(1):50-4. Epub 2011 Mar 21.
McAlpine, Dr. Jessica N.McAlpine JN, Gilks CB. Letter to the editor, Re: Han and colleagues, HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target. Histopathology, 2011 Jun;58(7):1173-4.
McAlpine, Dr. Jessica N.McAlpine JN, Vermorken JB, Wenzel LB. Survivorship in ovarian cancer. Accepted in Int J Gynecol Cancer. 2011 May;21(4):788-792.
McAlpine, Dr. Jessica N.Thigpen T, DuBois A, ….McAlpine JN….Fuijiwara K, Mannel R, DiSaia P, Pfisterer J. The Fourth Ovarian Carcinoma Consensus of the Gynecologic Cancer Intergoup: Clinical Trials Involving Patients with Newly Diagnosed Disease. Int J Gynecol Cancer. 2011 May;21(4):756-762.
McAlpine, Dr. Jessica N.McConechy M, Anglesio M, Kalloger SE, Yang W, Senz J, Chow C, Heravi-Moussavi A, Morin GB, Mes-Sasson A, Australian Ovarian Cancer Study Group, Carey MS, McAlpine JN, Kwon J, Prentice LM, Boyd N, Shah S, Gilks CB, Huntsman DG. Subtype specific mutation of PPP2R1A in endometrial and ovarian carcinomas. J Pathology. 2011 Apr; 223(5):567-73. doi: 10.1002/path.2848. Epub 2011 Mar 7.
McAlpine, Dr. Jessica N.Elit L, Jimenez W, McAlpine J, Ghatage P, Miller D, Plante M; Society of Obstetricians and Gynaecologists of Canada; Society of Gynecologic Oncology of Canada; Society of Canadian Colposcopists. SOGC-GOC-SCC joint policy statement. No. 255. March 2011. Cervical cancer prevention in low-resource settings. J Obstet Gynaecol Can 2011;33(3):272-9.
McAlpine, Dr. Jessica N.McAlpine JN, El-Hallani S, Lam SF, Kalloger SE; Luk M, Huntsman DG, MacAulay, C, Gilks CB, Miller DM, Lane PM. Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detection. Gynecol Oncol. 2011 Mar; 120(3):385-92. E pub 2011 Jan 14.
McAlpine, Dr. Jessica N.Lee C, Chiang S, McAlpine JN, Huntsman DG, Gilks CB, Fletcher J. 14-3-3 fusion oncogenes in endometrial cancer. Science, under review July 2011.
McAlpine, Dr. Jessica N.McAlpine JN, Porter H, Kalloger SE, Senz, J, Kalloger SE, Nelson B, Prentice L, Ding J, Milne K, Shah SP, Huntsman DG, Gilks CB. BRCA mutation and methylation status does not correlate with prognosis. Journal of Pathology, under review August 2011.
Money, Dr. Deborah M.Blasig A, Wagner EC, Pi D, Bigham M, Remple VP, Craib KJP, Doyle P, Dobson S, Yoshida EM, Patrick D, Krajden M, Money D, and the BC HCV Vertical Transmission Study Group. Hepatitis C Infection Among Pregnant Women in British Columbia: Reported Prevalence and Critical Appraisal of Current Prenatal Screening Methods. Canadian Journal of Public Health 2011; 102(2): 98-102.
Money, Dr. Deborah M.Saunders SJ, Weingarten LE, Maan E, Chaworth-Musters T, Forbes JC, Alimenti A, Mahy J, Burdge DR, van Schalkwyk JE, Tsang G, Quaia C, Hogg RS, Money D. Evaluation of an Emergency Prevention Program for Mother to Child Transmission of HIV in British Columbia. Journal of Obstetric Gynaecol Can 2011; 33(4): 338-343.
Money, Dr. Deborah M.Blitz S, Baxter J, Rabound J, Walmsely S, Coutlee F, Hankins C, Money D. The Canadian Women’s HIV Study Group. Canadian Journal of Infectious Diseases & Medical Microbiology. Vol 22, Suppl B, Spring 2011.
Money, Dr. Deborah M.Chaworth-Musters T, Fernandez E, Alimenti A, Maan E, Cote H, Money D, Forbes J. Adverse Health Outcomes in HIV Exposed Uninfected Children (HEU) in British Columbia – CIHR Team Grant in HIV Therapy and Aging (CARMA). Canadian Journal of Infectious Diseases & Medical Microbiology. Vol 22, Suppl B, Spring 2011.
Money, Dr. Deborah M.Eszter P, Ayu HP, Abozina A, Maan E, van Schlkwyk J, Money D, Cote HC. Lack of Change in Mitochondrial Function of HIV/HAART Exposed Placentae. Canadian Journal of Infectious Diseases & Medical Microbiology. Vol 22, Suppl B, Spring 2011.
Money, Dr. Deborah M.Money D, Walmsely S, Coutlee F, Rabound J, Blitz S. The Canadian HPV/HIV Study Group. . Canadian Journal of Infectious Diseases & Medical Microbiology. Vol 22, Suppl B, Spring 2011.
Money, Dr. Deborah M.Imam T, Jitratkosol M, Money D, Forbes J., Alimenti A, Beheroze S, Gadawski I, Mann E, Chaworth-Musters T, Cote H and CIHR Team Grant on HIV Therapy and Aging (CARMA) Cord Blood and Peripheral Blood Telomere Length in HIV-Infected HAART-Treated Pregnancies, CROI Boston 18th Conference on Retroviruses and Opportunistic Infections Conference on Retroviruses and Opportunistic Infections.
Pare, Dr. EmmanuellePare E. Fetal Physiology, In: NMS Obstetrics and Gynecology Seventh Edition, Pfeifer S (eds). Lippincott Williams & Wilkins, Philadelphia, 2011.
Pare, Dr. EmmanuelleJain VD, Moghbeli N, Webb G, Srinivas SK, Elovitz MA, Paré E. Pregnancy in women with congenital heart disease: the impact of a systemic right ventricle. Congenit Heart Dis. 2011 Mar;6(2):147-56.
Pare, Dr. EmmanuelleKim DR, Epperson N, Paré E, Gonzalez JM, Parry S, Thase ME, Cristancho P, Sammel MD, O’Reardon JP. An Open Label Pilot Study Of Transcranial Magnetic Stimulation For Pregnant Women with Major Depressive Disorder. J Womens Health (Larchmt). 2011 Feb;20(2):255-61.
Pare, Dr. EmmanuelleMcElrath TF, Rich-Edwars J, Lim KH, Paré E, Parry S. Longitudinal evaluation of circulating angiogenic factors for prediction of preeclampsia in a large contemporary North American cohort. Oral presentation, Society for Maternal-Fetal Medicine Annual Meeting, San Francisco, CA.
Pare, Dr. EmmanuelleTennant C, Friedman A, Paré E, Wang E. Risk for respiratory morbidity after an indeterminate or immature FLM-TDx test, but mature lecithin/sphingomyelin ratio. Poster presentation, Society for Maternal-Fetal Medicine Annual Meeting, San Francisco, CA.
Pressey, Dr. Tracy L.Young C, Pressey T, Lui S, Liston R, Joseph KS for the Maternal Health Study Group of the Canadian Perinatal Surveillance System. Mode of delivery following a previous cesarean and associated maternal and neonatal morbidity, Canada 2003-2008. Presented at the Perinatal Services BC, Occasional Seminar Series, Vancouver, BC (Supervisor for Carmen Young). September 2010.
Pressey, Dr. Tracy L.Young C, Pressey T, Lui S, Liston R, Joseph KS for the Maternal Health Study Group of the Canadian Perinatal Surveillance System. Mode of delivery following a previous cesarean and associated maternal and neonatal morbidity, Canada 2003-2008. Presented at the University of BC, Department of Obstetrics and Gynecology, Annual Academic Day (Supervisor for Carmen Young). March 9, 2011.
Pressey, Dr. Tracy L.Young C, Pressey T, Lui S, Liston R, Joseph KS for the Maternal Health Study Group of the Canadian Perinatal Surveillance System. Mode of delivery following a previous cesarean and associated maternal and neonatal morbidity, Canada 2003-2008. Presented at the Western Perinatal Research Meeting (Supervisor for Carmen Young). February 2011.
Rowe, Dr. Timothy C.Journal metrics (editotorial). J Obstet Gynaecol Can 2011;33:575-6.
Rowe, Dr. Timothy C.Rowe TC. Facing the music (editorial). J Obstet Gynaecol Can 2011;33:203-4.
Rowe, Dr. Timothy C.Rowe TC. Physician leaders (editorial). J Obstet Gynaecol Can 2011;33:107-8.
Rowe, Dr. Timothy C.Rowe TC. Privacy (editorial). British Columbia Medical Journal. 2011; 53: 110.
Rowe, Dr. Timothy C.Rowe TC. The official voice (editorial). J Obstet Gynaecol Can 2011;33:11-12.
Rowe, Dr. Timothy C.Rowe TC. Weight watchers (editorial). J Obstet Gynaecol Can 2011;33:431-2.
Rurak, Dr. Dan W.Rurak D, Lim K, Sanders A, Brain U, Riggs W, Oberlander TF. Third Trimester Fetal Heart Rate and Doppler Middle Cerebral Artery Blood Flow Velocity Characteristics during prenatal Selective Serotonin Reuptake Inhibitor (SSRI) exposure. Pediatr Res, in press, March 2011.
Rurak, Dr. Dan W.Chow T, Nguyen TA, Rurak D, Riggs W. Pharmacokinetics of fluoxetine in newborn lambs. Western Perinatal Research Meeting, Banff, Alberta, February 2011.
Rurak, Dr. Dan W.Nguyen TA, Chow T, Riggs, W, Rurak D. Lack of fluoxetine effects in postnatal lambs. Western Perinatal Research Meeting, Banff, Alberta, February 2011.
Rurak, Dr. Dan W.Preetheban M, Hammon G, Bandiera AS, Riigs, W, Rurak D. Ontogenesis of UDP-glucuronosyltranferase enzymes in sheep. Comp Biochem Physiol A Mol Integr Physiol, in press Feb 2011.
Rurak, Dr. Dan W.Chow TW, Szeitz A, Rurak DW, Riggs KW. A validated enantioselective assay for the simultaneous quantitation of (R)-, (S)-fluoxetine and (R)-, (S)-norfluoxetine in ovine plasma using liquid chromatography with tandem mass spectrometry (LC/MS/MS). J Chromatogr B 879:349-358, 2011.
Rurak, Dr. Dan W.von Dadelszen P, Dinwell S, Magee L, Carlton B, Gruslin, A, Lee B, Lim K, Liston R, Miller S, Rurak D, Sherlock R, Skoll M, Wareing M, Baker P for the Research into Advanced Fetal Diagnosis and Therapy (RAFT) Group. Sildenafil citrate therapy for severely early-onset intrauterine growth restriction. BJOG 118:624-628, 2011.
Tessier, Dr. FrancineYong PJ, von Dadelszen P, Carpara D, Lim K, Kent N, Tessier F, Delisle MF, Wong T, Blair G, Skarsgard ED. Prediction of pediatric outcome after prenatal diagnosis and expectant antenatal management of congenital cystic adenomatoid malformation. Submitted to Fetal Diagnosis and Therapy 2011.
von Dadelszen, Dr. PeterAlper AB, Rahman M, Yi Y, Webber LS, Magee LA, von Dadelszen P, Pridjian G, Aina-Mumuney A, Saade G, Morgan J, Nuwayhid B, Belfort M, Puschett J. Performance of estimated glomerular filtration rate prediction equations in preeclamptic patients. Am J Perinatol [Epub ahead of print] (PMID: 21089008) [funding: CIHR, MSFHR, CFRI].
von Dadelszen, Dr. PeterBourque DK, Avila L, Peñaherrera M, von Dadelszen P, Robinson WP. Imprinting control region methylation and gene expression patterns at 11p15 in placentas associated with intrauterine growth restriction and/or preeclampsia. Prenat Diagn (in press). [Role: study design; funding co-applicant; manuscript preparation; funding: CIHR, MSFHR, CFRI].
von Dadelszen, Dr. PeterHutcheon J, Lisonkova S, Magee L, von Dadelszen P, Woo H, Liu S, Joseph K. Optimal timing of delivery in pregnancies with pre-existing hypertension. BJOG 2011;118:49-54 (PMID: 21054760). [Role: research question, data interpretation, manuscript preparation; funding: CIHR, MSFHR, CFRI].
von Dadelszen, Dr. PeterIglesias MH, von Dadelszen P, Magee LA. Postpartum hyperkalemia associated with magnesium sulfate. Hypertens Pregnancy 2010 [Epub ahead of print] (PMID: 20701474). [Role: manuscript preparation; funding: CIHR, MSFHR, CFRI].
von Dadelszen, Dr. PeterMagee LA, von Dadelszen P, Allen VM, Ansermino JM, Audibert F, Barrett J, Brant R, Bujold E, Crane JMG, Demianczuk N, Joseph KS,. Lee SK, Piedboeuf B, Smith G, Synnes A, Walker M, Whittle W, Wood S, Lee T, Li J, Payne B, Liston RM, MBChB, for the Canadian Perinatal Network Collaborative Group. The Canadian Perinatal Network: A National Network Focused on Threatened Preterm Birth at 22 to 28 Weeks’ Gestation. J Obstet Gynaecol Can (in press). [funding: CIHR
von Dadelszen, Dr. PeterThornton CE, von Dadelszen P, Makris A, Tooher JM, Ogle RF, Hennessy A. Acute pulmonary oedema as a complication of hypertension during pregnancy. Hypertens Pregnancy 2010 [Epub ahead of print] (PMID: 19900075). [Role: study design; data analysis; manuscript preparation; funding: CIHR, MSFHR, CFRI].
von Dadelszen, Dr. Petervon Dadelszen P, Dwinnell S, Magee LA, Carleton BC, Gruslin A, Lee B, Lim KI, Liston RM, Miller SP, Rurak D, Sherlock RL, Skoll MA, Wareing MM, Baker PN, for the Research into Advanced Fetal diagnosis and Therapy (RAFT) Group. Sildenafil citrate therapy for early-onset severe intrauterine growth restriction. BJOG (in press). [funding: CIHR, MSFHR, CFRI].
von Dadelszen, Dr. Petervon Dadelszen P, Payne B, Menzies JM, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Merialdi M, Millman AL, Moore MP, Moutquin JM, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JR, Magee LA, for the PIERS Study Group. Predicting adverse maternal outcomes in pre-eclampsia: the fullPIERS (Pre-eclampsia Integrated Estimate of RiSk) model – developm
Top Of Page

a place of mind, The University of British Columbia

Department of Obstetrics and Gynaecology
1190 Hornby Street - 4th Floor
Vancouver BC V6Z 2K5
Tel: [604.875.2021]
Contact: webmaster

Emergency Procedures | Accessibility | Contact UBC | © Copyright The University of British Columbia